Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Why The AbbVie (ABBV) Story Is Shifting As Immunology Hopes Meet Valuation Doubts
AbbVie Sues US Over Patients Eligible for Drug Discount Program
Cantor Fitzgerald Lowers AbbVie (NYSE:ABBV) Price Target to $240.00
BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year | Morningstar
Naviter Wealth LLC Has $3.75 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily
AbbVie's Humira TrumpRx Discount Recasts Pricing Risks And Policy Role
AK Global Asset Management LLC Buys New Shares in AbbVie Inc. $ABBV
MBL Wealth LLC Boosts Stake in AbbVie Inc. $ABBV - Stock Observer
Yousif Capital Management LLC Decreases Stock Holdings in AbbVie Inc. $ABBV - Daily Political
Can AbbVie's (ABBV) New Dermatology Data Quietly Reshape Its Immunology-Heavy Investment Story?
AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns
69,065 Shares in AbbVie Inc. $ABBV Acquired by Robinhood Asset Management LLC
Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin
AbbVie Inc. $ABBV Shares Sold by Sound Income Strategies LLC
Humira's TrumpRx Discount Raises New Questions For AbbVie Valuation
AbbVie Inc. $ABBV Stake Lowered by Albion Financial Group UT
AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts
Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says | Markets Insider
Two more pharmaceutical companies, Abbvie and Genentech, to officially launch on TrumpRx - CBS News
AbbVie (NYSE:ABBV) Stock Price Down 1.1% - Time to Sell?
High Yield vs. Sustainable Growth: Why AbbVie's Dividend Beats Pfizer's Despite the Lower Payout - 24/7 Wall St.
9 Newly Overvalued Stocks this Week | Morningstar
Trueblood Wealth Management LLC Buys 2,793 Shares of AbbVie Inc. $ABBV - Markets Daily
Pharmaceutical Stocks To Watch Now - April 6th - Daily Political
AbbVie forecasts $744M hit from drug pipeline costs
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won't Pay a Dime | Investing.com
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
ABBVIE SP. Z O.O. secures contract for Various medicinal products
Analysts' Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF) | Markets Insider
Clipping a 12% Coupon on a Big Pharma Name
AbbVie Inc. $ABBV Shares Purchased by Kelleher Financial Advisors
AbbVie Inc. $ABBV Shares Purchased by JB Capital LLC
AbbVie Inc. $ABBV is Advocate Group LLC's 4th Largest Position
Kelleher Financial Advisors Boosts Stock Position in AbbVie Inc. $ABBV - Daily Political
Toth Financial Advisory Corp Buys 3,300 Shares of AbbVie Inc. $ABBV - Stock Observer
Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily
How Investors Are Reacting To AbbVie (ABBV) Dermatology Data, Governance Debate and Rising Tariff Risk
Potential US Drug Tariffs Test AbbVie Margins And Growth Narrative
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer
Sensor-based digital health technologies to capture endpoints in recent clinical trials: a scoping review
ABBVIE SP. ZO.O. secures contract for Pharmaceutical products, Pharmaceutical products
Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology
AbbVie (NYSE:ABBV) Stock Price Up 2% - Here's What Happened - Daily Political
Best Pharmaceutical Stocks To Follow Now - April 2nd - Daily Political
Tema Etfs LLC Raises Stock Holdings in AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Shares Sold by Trust Co. of Vermont
Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update
Compagnie Lombard Odier SCmA Raises Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Stock Holdings Trimmed by Trust Co. of Vermont - Daily Political
Abbvie Inc. (ABBV) - Insider Monkey
Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensus
AbbVie (NYSE:ABBV) Shares Down 1.3% - Time to Sell?
Is It Too Late To Consider AbbVie (ABBV) After Its Recent Share Price Swings?
AbbVie (NYSE:ABBV) Shares Up 1.8% - Here's Why - Stock Observer
Meyer Handelman Co. Boosts Stock Holdings in AbbVie Inc. $ABBV
Capital Advisors Inc. OK Raises Stake in AbbVie Inc. $ABBV
Nisa Investment Advisors LLC Acquires 204,761 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Allspring Global Investments Holdings LLC
AbbVie Inc. $ABBV Stock Holdings Trimmed by Vaughan Nelson Investment Management L.P. - Daily Political
AbbVie (NYSE:ABBV) Shares Up 2% - Time to Buy?
Pharmaceutical Stocks To Watch Today - March 31st
AbbVie Leans Into Consumer Aesthetics With CoolMonth And Neurotoxin Pipeline
Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players
Range Financial Group LLC Has $1.08 Million Stock Holdings in AbbVie Inc. $ABBV
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
AbbVie Inc. $ABBV Holdings Lifted by Mn Services Vermogensbeheer B.V.
Range Financial Group LLC Has $1.08 Million Holdings in AbbVie Inc. $ABBV - Stock Observer
J. Safra Sarasin Holding AG Has $71.14 Million Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Stock Price Up 1.8% - Should You Buy?
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD) | Morningstar
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
AbbVie Inc. $ABBV Stock Position Raised by TrueMark Investments LLC
AbbVie Inc. $ABBV Shares Acquired by Stegent Equity Advisors Inc.
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
TrueMark Investments LLC Acquires 4,878 Shares of AbbVie Inc. $ABBV - Stock Observer
Assessing AbbVie (ABBV) Valuation After New Dermatology Data Underpins Immunology Growth Potential
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Infographic: teprotumumab for the treatment of active thyroid eye disease
AbbVie Inc. $ABBV Stock Holdings Lifted by Waycross Partners LLC
Top Pharmaceutical Stocks To Follow Now - March 29th - Daily Political
Bell Bank Has $12.09 Million Stake in AbbVie Inc. $ABBV
AbbVie Dermatology Data Sparks Questions On Growth Potential And Valuation
AbbVie Dermatology Data Highlights Immunology Depth And Emerging Skin Disease Opportunities
Wealthcare Advisory Partners LLC Grows Stake in AbbVie Inc. $ABBV
Top Pharmaceutical Stocks To Watch Today - March 25th - Markets Daily
TABR Capital Management LLC Takes Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Capital Investment Advisors LLC
Hourglass Capital LLC Sells 3,960 Shares of AbbVie Inc. $ABBV - Stock Observer
Generate Investment Management Ltd Sells 49,224 Shares of AbbVie Inc. $ABBV - Stock Observer
Exchange Traded Concepts LLC Grows Holdings in AbbVie Inc. $ABBV - Stock Observer
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
AbbVie call volume above normal and directionally bullish | Markets Insider
AbbVie News
Super Micro Computer Inc (NASDAQ: SMCI) stock outlook: SMCI shares rise 2.8%, what’s next?
Siren (SIREN) Price Analysis: SIREN Crypto Short-Term Outlook and Risks
UAE Financial Market Analysis 2026: Banking Profits, Crypto & Blockchain, Digital Finance Revolution
High potential ai stocks: Arm Holdings (ARM) stock, ASML stock, ASMI stock
Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook
Latest news
Show more
Gold Price Today, April 8: XAU/USD Surges Toward $4,900 as US-Iran Agree to Two-Week Ceasefire
Stock Market Today: IonQ, Rigetti, D-Wave, What’s going on with Quantum Computing Stocks?
Gold Price Today, April 7: XAU/USD Hovers Near $4,660 Ahead of Key US Inflation Data
US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases
SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation
